About Dr. Rifkin
Robert M. Rifkin, M.D., was inspired to pursue a career that would allow him to compassionately care for patients. Dr. Rifkin offers state-of-the-art cancer treatment while taking into account the effects that each choice has on the patient's overall quality of life. He listens to each patient's individual concerns, and he values the importance of each patient's understanding of benefits and risks arising from the choices that they make while under his care. Dr. Rifkin remains abreast of new advancements in technology and medicine and is renowned for his constructive contributions to research-focused publications and his outstanding cancer research.
Rocky Mountain Cancer Center and Cambridge Who’s Who
A physician for Rocky Mountain Cancer Centers, Dr. Rifkin has been recognized by Cambridge Who’s Who for showing dedication, leadership and excellence in oncology and hematology. He has 22 years of experience in the field of oncology and hematology, as well as extensive expertise in multiple myeloma and donor evaluations. At Rocky Mountain Cancer Centers, he is responsible for assisting and mentoring medical fellows and residents and conducting research.
- Founder of Rocky Mountain Blood and Marrow Transplant Program, 2003
- Clinical Associate Professor of Medicine, Department of Internal Medicine, Division of Medical Oncology, University of Colorado School of Medicine,
- Inspector, Foundation for Accreditation of Cellular Therapy
- Member, Executive Board of Directors, National Patient Advocate Foundation
- Colorado State Chair, National Patient Advocate Foundation
- Medical Director of Biosimilars, McKesson Specialty Health, US Oncology Research
- Medical Director of Stem Cell Transplant Research, US Oncology Research
Dr. Rifkin graduated with honors from The Colorado College at Colorado Springs with a B.A. degree. He also graduated with honors the University of Colorado School of Medicine at Denver, where he earned an M.D. He completed training as a Summer Research Fellow of the Colorado Diabetes Research Foundation in Denver, and as a Summer Research Fellow at the KROC Foundation. Dr. Rifkin served as a Categorical Internal Medicine Intern at the University of Colorado Health Sciences Center, and as an internal medicine resident at the Presbyterian/St. Luke’s Medical Center. He was a research associate at the Division of Medical Oncology for the University of Colorado Health Sciences Center, and a hematology and oncology fellow at the University of Arizona Health Sciences Center in Tucson.
Certifications and Teaching
Dr. Rifkin is licensed in both the States of Colorado and Arizona. He is a member of the National Honor Society, Phi Beta Kappa and Alpha Omega Alpha. He also has been accredited with board certifications by the National Board of Medical Examiners, the American Board of Internal Medicine, the American Board of Internal Medicine, Subspecialty of Hematology, and the American Board of Internal Medicine, Subspecialty of Medical Oncology.
Dr. Rifkin has served as a clinical assistant professor of internal medicine in hematology and oncology at the University of Arizona College of Medicine from 1988 to 1990. In the same year, he served as an associate director of bone marrow transplantation at the Institute of Higher Education. Dr. Rifkin went on to serve as a clinical professor of surgery at the Department of Surgery in the Division of Organ Transplantation at the University of Colorado Health Sciences Center in Denver from 1991 to 1996.
Medical Director and Committee Roles
Ever-motivated to gain knowledge of the field in order to assist patients by providing them with the utmost care, Dr. Rifkin now serves as a medical director of the Rocky Mountain Blood and Marrow Transplant Program in Denver, a role that he has maintained since 1990. He also has functioned as a medical director of the Hematopoletic Progenitor Cell Processing Laboratory, and of Clinical Apheresis at HealthONE – Presbyterian/St. Luke’s Medical Center since 1990. Dr. Rifkin is medical director of the National Marrow Donor Program Collection Center (#266), medical director of Colorado Coagulation Consultants, national chairman of the Blood and Marrow Transplant Committee of US Oncology in Houston, national chairman of the Disease Management Partnership Committee at US Oncology & Alza Pharmaceuticals, medical director of US Oncology Stem Cell Transplant Research, and clinical instructor of medicine at the Department of Internal Medicine for the University of Colorado School of Medicine.
Dr. Rifkin is an inspector for the College of American Pathologists and a member of several industry-related organizations and societies. In his commitment to remain informed of developments in medicine and science, Dr. Rifkin serves as a fellow of the American College of Physicians, and as a member of the American Association of the Advancement of Science. He is also a member of the American Society of Hematology, the American Society of Clinical Oncology, the American Association of Blood Banks, the Colorado Medical Society and the Denver Medical Society. Dr. Rifkin is affiliated with the Hemophilia Research Society, the International Society for Hemostasis and Thrombosis, the American Society for Apheresis, the International Society for Hematotherapy and Graft Engineering, the American Society for Blood and Marrow Transplantation, the American Society for Histocompatibility and Immunogenetics, and the American Society of Clinical Pathology.
With more than two decades of experience in the field of oncology and hematology, Dr. Rifkin anticipates a bright future that will embrace emerging technologies and treatment options. Dr. Rifkin looks forward to treating patients and increasing their access to medications in the years to come.